Home
About Leecan
Overview of Leecan
History
Corporate Culture
Honor
Responsibility
Product
Marketed Products
Regulatory Review
In Development
Production and Research Platform
Research and Development Platform
Production and Operation
Quality Assurance
CMO/CDMO
News regulations
Investor
Careers
Talent Concept
People in leecan
Recruitment
Career development
Contact Us
Cooperation
Supplier Cooperation
Recruitment
Pharmacovigilance
CMO/CDMO
EN
/
CN
Home
About Leecan
Overview of Leecan
History
Corporate Culture
Honor
Responsibility
Product
Marketed Products
Regulatory Review
In Development
Production and Research Platform
Research and Development Platform
Production and Operation
Quality Assurance
CMO/CDMO
News regulations
Investor
Careers
Talent Concept
People in leecan
Recruitment
Career development
Contact Us
Cooperation
Supplier Cooperation
Recruitment
Pharmacovigilance
CMO/CDMO
Issue 2: Monthly Report on Pharmaceutical Regulatory Laws
Release time：2026-07-06
share:
Previous article：Issue 3: Innovative Drugs and AI Empowerment: A Quick Look at New Pharma Regulations
next article：Issue 1 New Drugs Policy and Updated Clinical Trial Standards
Back to list
You may also want to read
The discussion meeting for the Phase III clinical trial protocol of beclomethasone dipropionate inhalation aerosol was successfully held
2025.07.11
The working committee of the Medical and Health Industry Alliance of Jiangsu Health Industry Research Association visited Nanjing Leecan Pharmaceutical for research and exchange
2026.08.03
Leecan of Hefei base carried out corporate culture publicity
2024.07.25
